Paragon 28 To Report Second Quarter 2022 Financial Results on August 3, 2022
18 Juli 2022 - 2:00PM
Business Wire
Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical
device company exclusively focused on the foot and ankle orthopedic
market, announced it will report financial results for the second
quarter 2022 after market close on Wednesday, August 3, 2022. The
company’s management will webcast a corresponding conference call
beginning at 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do
so by dialing (844-200-6205) for domestic callers or (929-526-1599)
for international callers, using conference ID: 990038. Live audio
of the webcast will be available on the “Investors” section of the
company’s website at: ir.paragon28.com. The webcast will be
archived and available for replay for at least 90 days after the
event.
About Paragon 28, Inc.
Based in Englewood, Colo., Paragon 28, is a leading medical
device company exclusively focused on the foot and ankle orthopedic
market and is dedicated to improving patient lives. From the onset,
Paragon 28® has provided innovative orthopedic solutions,
procedural approaches and instrumentation that cover a wide range
of foot and ankle ailments including fracture fixation, hallux
valgus (bunions), hammertoe, ankle, progressive collapsing foot
deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The
company designs products with both the patient and surgeon in mind,
with the goal of improving outcomes, reducing ailment recurrence
and complication rates, and making the procedures simpler,
consistent, and reproducible.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220718005316/en/
Investor Contact: Gilmartin Group Matt Bacso, CFA
Matt.bacso@gilmartinir.com
Paragon 28 (NYSE:FNA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Paragon 28 (NYSE:FNA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024